These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35661074)

  • 1. BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).
    Lombardi L; Trumello C; Stuppia L; Antonucci I; Brandão T; Babore A
    J Assist Reprod Genet; 2022 Jul; 39(7):1433-1443. PubMed ID: 35661074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
    Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
    Rubin LR; Werner-Lin A; Sagi M; Cholst I; Stern R; Lilienthal D; Hurley K
    Hum Fertil (Camb); 2014 Sep; 17(3):159-64. PubMed ID: 25105219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
    Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
    Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
    Mor P; Brennenstuhl S; Metcalfe KA
    J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.
    Dagan E; Birenbaum-Carmeli D; Friedman E; Feldman B
    J Genet Couns; 2017 Oct; 26(5):1070-1079. PubMed ID: 28265801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
    Dervin T; Ranisavjevic N; Laot L; Mayeur A; Duperier C; Steffann J; Borghese R; Stoppa-Lyonnet D; Frydman N; Benachi A; Sonigo C; Grynberg M
    J Assist Reprod Genet; 2023 Jun; 40(6):1381-1390. PubMed ID: 37154838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
    Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
    Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008).
    van Rij MC; de Koning Gans PA; van Belzen MJ; Roos RA; Geraedts JP; De Rademaeker M; Bijlsma EK; de Die-Smulders CE
    Clin Genet; 2014 Jan; 85(1):87-95. PubMed ID: 23350580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.
    Goetsch AL; Wicklund C; Clayman ML; Woodruff TK
    J Genet Couns; 2016 Jun; 25(3):561-71. PubMed ID: 26567039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
    J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.
    Drüsedau M; Dreesen JC; Derks-Smeets I; Coonen E; van Golde R; van Echten-Arends J; Kastrop PM; Blok MJ; Gómez-García E; Geraedts JP; Smeets HJ; de Die-Smulders CE; Paulussen AD
    Eur J Hum Genet; 2013 Dec; 21(12):1361-8. PubMed ID: 23531862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
    Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer.
    Julian-Reynier C; Chabal F; Frebourg T; Lemery D; Noguès C; Puech F; Stoppa-Lyonnet D
    J Clin Oncol; 2009 Sep; 27(27):4475-80. PubMed ID: 19704065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants.
    Vuković P; Peccatori FA; Massarotti C; Miralles MS; Beketić-Orešković L; Lambertini M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103201. PubMed ID: 33333149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.